Legato Capital Management’s Biodesix BDSX Stock Holding History

Legato Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.84M	Buy	81,381 +40,207	+98%	+$596K	0.15%	202
2026 Q1	$597K	Buy	+41,174	New	+$510K	0.05%	498
2024 Q4	–	Sell	-16,716	Closed	-$595K	–	573
2024 Q3	$595K	Hold	16,716	–	–	0.07%	416
2024 Q2	$511K	Hold	16,716	–	–	0.07%	435
2024 Q1	$478K	Hold	16,716	–	–	0.06%	449
2023 Q4	$615K	Hold	16,716	–	–	0.08%	373
2023 Q3	$552K	Sell	16,716 -982	-6%	-$27.3K	0.08%	377
2023 Q2	$435K	Buy	17,698 +7,445	+73%	+$223K	0.06%	452
2023 Q1	$381K	Buy	10,253 +8,655	+542%	+$355K	0.07%	392
2022 Q4	$73.5K	Buy	+1,598	New	+$43.4K	0.01%	482

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Legato Capital Management's BDSX Position: Q2 2026 in Review

Legato Capital Management increased its Biodesix (BDSX) stake by 98% in Q2 2026, buying an estimated $596K and bringing the position to 81,381 shares worth $1.84M. The position accounts for 0.15% of the portfolio, ranked #202.

Legato Capital Management first reported a position in BDSX in Q4 2022 and has held it in 10 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

Legato Capital Management held 81,381 shares of Biodesix worth $1.84M as of Q2 2026.
Legato Capital Management bought 40,207 Biodesix shares in Q2 2026, an estimated $596K.
Biodesix made up 0.15% of Legato Capital Management's portfolio in Q2 2026, its #202 holding.
Legato Capital Management first reported a position in Biodesix in Q4 2022 and has held it in 10 quarters since.
45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.